Contracts › 75A50120C00177
75A50120C00177: To Develop Medical Countermeasures (MCMS) That Treat Antibiotic Resistant Infections.
Awarded to Vedanta Biosciences, Inc. by Office of Assistant Secretary for Preparedness and Response.
$99.1Mobligated
$134.1Mpotential value
31 August 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75A50120C00177 |
|---|---|
| Awardee | Vedanta Biosciences, Inc. |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AZ13 R&D- Other Research and Development (Advanced Development) |
| Place of performance | MA |
| Offers received | 1 |
| Period of performance | 28 September 2020 to 31 August 2027 |
| Potential end | 31 December 2031 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record